Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of human umbilical cord mesenchymal stem cell injection for moderate to severe systemic lupus erythematosus
CTR20244802Phase 2Active
- Sponsor
- Beike Biotechnology
- Start
- Apr 2025
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cell in systemic lupus erythematosus (SLE), sponsored by Beike Biotechnology. Started Apr 2025; status: active.
02
Drugs
human umbilical cord mesenchymal stem cell
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20244802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244802.